No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Biopsy, Needle
-
Carcinoma, Non-Small-Cell Lung / drug therapy*
-
Carcinoma, Non-Small-Cell Lung / pathology
-
Carcinoma, Non-Small-Cell Lung / surgery
-
Follow-Up Studies
-
Gefitinib
-
Humans
-
Immunohistochemistry
-
Lower Extremity
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / pathology
-
Lung Neoplasms / surgery
-
Male
-
Middle Aged
-
Necrosis / chemically induced
-
Necrosis / drug therapy
-
Neoplasm Invasiveness / pathology
-
Neoplasm Staging
-
Prednisolone / administration & dosage
-
Quinazolines / adverse effects*
-
Quinazolines / therapeutic use
-
Risk Assessment
-
Skin Diseases, Vascular / chemically induced*
-
Skin Diseases, Vascular / drug therapy
-
Skin Diseases, Vascular / pathology
-
Treatment Outcome
-
Vasculitis / chemically induced*
-
Vasculitis / drug therapy
-
Vasculitis / pathology
Substances
-
Antineoplastic Agents
-
Quinazolines
-
Prednisolone
-
Gefitinib